Safety and efficacy of the choline analogue SAR97276 for malaria treatment: results of two phase 2, open-label, multicenter trials in African patients

Article English OPEN
Jana Held; Christian Supan; Carmen L. Ospina Salazar; Halidou Tinto; Léa Nadège Bonkian; Alain Nahum; Ali Sié; Salim Abdulla; Cathy Cantalloube; Elhadj Djeriou; Marielle Bouyou-Akotet; Bernhards Ogutu; Benjamin Mordmüller; Andrea Kreidenweiss; Mohamadou Siribie; Sodiomon B. Sirima; Peter G. Kremsner;

Background Malaria remains one of the most important infectious diseases. Treatment options for severe malaria are limited and the choline analogue SAR97276A is a novel chemical entity that was developed primarily as treatment for severe malaria. Before starting clinica... View more
Share - Bookmark